Skip to main content
Watch Insiders
CTNM filings

Corporate insider profile

Daniel S. Lorrain Filing Activity

Latest reported as Chief Scientific Officer of Contineum Therapeutics, Inc. (CTNM).

Purchase filings
0
Reported companies
1
Net open-market value
-$109,556.33
Latest transaction
Jun 1, 2026

Affiliated corporations

Reported company relationships

CTNMLatest reported

Contineum Therapeutics, Inc.

Chief Scientific Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 1, 2026Contineum Therapeutics, Inc. (CTNM)Chief Scientific OfficerSale4,170$13.16$54,862
May 1, 2026Contineum Therapeutics, Inc. (CTNM)Chief Scientific OfficerSale4,170$13.12$54,694